Syon Capital »

Takeda Pharmaceutical shares owned by Syon Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Syon Capital from 13F filings

Historical chart of Syon Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Syon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Syon Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $886k 62k 14.22

More positions owned by Syon Capital

Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Invesco Emerging Markets Sovereign Debt Etf Etf (PCY)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Ishares Gold Trust Etf (IAU)
Ishares Msci China Etf Etf (MCHI)
Ishares Msci Global Gold Miners Etf Etf (RING)
Vaneck Clo Etf Etf (CLOI)

View all positions for Syon Capital

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical